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ABSTRACT 
GENE EXPRESSION RESPONSE IN EARLY DEVELOPMENTAL STAGES OF 
RAINBOW TROUT EXPOSED TO ECOLOGICALLY RELEVANT 
CONCENTRATIONS OF MALATHION 
 
by  
 
Susan L. Miller 
 
The University of Wisconsin-Milwaukee, 2012 
Under the Supervision of Professor Michael J. Carvan 
 
Abstract. Understanding the early life stage toxic effects of environmental 
organophosphate exposure on organism health is crucial to identifying 
biomarkers that can be used for preventative care.  Malathion, a potent 
organophosphate, is one of the most widely used organophosphates in 
agriculture and pest eradication.  Due to its widespread use, pesticide runoff into 
area bodies of water poses a great threat to aquatic life and human inhabitants.  
Acute exposure to high concentrations of malathion causes neurological 
abnormalities and can result in respiratory failure, muscle spasms, and mental 
confusion in humans.  
 In the present study, the effects of malathion are observed following acute, 
low-level exposure; however, most diagnostic tests require sustained exposure to 
concentrations high enough to induce acetylcholinesterase inhibition. There is a 
direct relationship between AChE inhibition and acute exposure to malathion, 
that results in systematic disturbances in neural function and elicits overt toxicity.  
While disrupted AChE activity serves as a biomarker, it is not sensitive to low 
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levels of malathion exposure. Therefore, it is necessary to identify novel 
biomarkers that are more sensitive to malathion exposure so that steps can be 
taken to ensure the safety of humans and aquatic life before the neurological 
complications can develop. 
 Here were we report the discovery of two new potential biomarkers that are 
expressed following acute, low-concentration malathion exposure. We used two 
early life stages of rainbow trout (sac fry and swim-up fry) exposed to varying 
malathion levels (3-100 parts per billion, ppb) over 48 hours. At these levels, 
swim-up fry had heightened mortality rates compared to sac fry, indicating that 
they may exhibit change in gene expression.  To identify transcriptional 
biomarkers, a 16K salmonid cDNA microarray was used; 349 genes were found 
to be differentially expressed at concentrations as low as 10 ppb.  Additionally, 
we further analyzed malathion responsive genes using qPCR, network and 
ontologic analysis. The results from qPCR revealed that the gene encoding for a 
small heat shock protein, HSP30, was robustly upregulated.  A second gene put 
forth as a candidate biomarker in this study is cytochrome P4501A3 (CYP1A3); 
this study also shows paralog CYP1A1 was not found to be malathion inducible 
in either life stage. Network and ontologic analysis suggested changes in 
expression of genes involved in metal ion binding, catalytic activity, transport, 
oxidation-reduction, metabolism and stress response. The novel findings of this 
study contribute to the construction of a repertoire of predictive biomarkers, 
induced by malathion exposure, that may also be used as tools to survey fish 
population health. 
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Introduction 
The usage of pesticides, fungicides and herbicides in standard agricultural 
practice results in a high probability of contamination of aquatic habitats and 
ground water reservoirs due to pesticide run-off and ground infiltration.  The 
toxicity of prevalently used organophosphate (OP) agrochemicals is well studied; 
in humans, symptoms of acute poisoning include respiratory failure, muscle 
spasms, and mental confusion (Haque et al., 1987; Sweeney and Lyon, 1999).  
Unfortunately, a dichotomy often exists between pesticide effectiveness and 
safety; this provides for challenges in management and regulation of such 
pesticides. The OP malathion [1,2-Di(ethoxycarbonyl)ethyl O,O-dimethyl 
phosphorodithioate], a widely used chemical compound classified as a broad 
spectrum insecticide, exemplifies such a challenge.  Malathion poses a moderate 
to high toxicity in fish species, where concentrations as low as 4 parts per billion 
(ppb) have been shown to adversely affect trout species (U.S. EPA, 2000); yet, 
water concentrations as high as 583 ppb have been reported to be found in 
bodies of water near pesticide application sites (Ando, 1994). Thus, prevalence 
of malathion contamination in biologically significant amounts presents a toxic 
hazard toward freshwater eco-systems.   
The mechanisms that underlie malathion’s adverse effects in fish are 
beginning to be understood.  One well-studied adverse effect is 
acetylcholinesterase inhibition in both target and non-target species (Chambers 
and Carr, 1995).  AChE is essential for cholinergic neurotransmission and 
functions to catalyze the hydrolysis of the neurotransmitter acetylcholine (ACh).  
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Sustained high levels of AChE inhibition induced by acute exposure to malathion 
systemically disturb neural function. In fish, aberrant behaviors associated with 
acute OP toxicity include erratic swimming, hyperexcitability, loss of equilibrium, 
and caudal bending (Patil and David, 2010).  Malathion also manifests pro-
oxidative properties (Banerjee et al., 1999) capable of eliciting lipid peroxidation 
in rodent erythrocytes, liver and brain tissues (Hazarika et al., 2003) and 
mitogenic effects (Moore et al., 2010).  Importantly, changes at the level of gene 
expression provide clues as to the molecular mechanisms of malathion toxicity in 
organisms ranging from fish to humans, yet this has not been well investigated. 
Due to this, we hypothesized that genes found to be consistently dysregulated by 
malathion are suitable biomarkers to detect low-level malathion exposure.  
In the present study, we investigated the molecular consequences of 
malathion low-level exposure using Oncorhynchus mykiss (rainbow trout). 
Rainbow trout are uniquely suited to this analysis because they exhibit a 
heightened sensitivity to environmental OPs and can serve as a biological 
detector.  In our investigation, we profiled malathion-mediated changes both in 
vivo and using gene expression analysis to identify candidate biomarkers.  
Malathion responsive genes were identified from two distinct early developmental 
stages of rainbow trout fry at environmentally relevant concentrations.  We found 
two robust biomarkers that had dramatic changes in expression levels that 
occurred during malathion-induced morbidity.  Moreover, we used network 
analysis to identify other potential biomarkers of malathion toxicity when the fish 
were exposed to very low levels.  
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Methods 
Procurement of Oncorhynchus mykiss eggs 
Rainbow trout eyed eggs were obtained from U.S. Fish and Wildlife 
Service Ennis National Fish hatchery (Ennis, MT). Embryos were group housed 
in a flow-through tank system where dissolved oxygen levels (> 10 mg/L) and 
temperature (10.0 ± 1.0 °C) were maintained with a 12 h light:12 h dark 
photoperiod. All embryo and fish rearing and use were conducted in accordance 
to the guidelines established by the Animal Care and Use Committee (ACUC) of 
University of Wisconsin-Milwaukee. 
 
Malathion exposure regimen 
Two developmental stages (One-day post-hatch sac fry and 14-days post-
hatch swim-up fry) of rainbow trout were used, all arising from the same 
hatchery-reared cohort of embryos.  These life stages of fish were subjected to a 
malathion exposure for 48 hours. Ten fish per beaker were exposed to either a 
single waterborne malathion (Chem Service Inc., West Chester, PA) treatment or 
ethanol vehicle following a 24-hour acclimation period.  On the day of exposure, 
malathion was dissolved in ethanol (the lowest volume was used so as to be 
miscible in water and was calculated to be 0.0001% of total exposure volume) 
before being mixed with water.  Fish were exposed by static renewal to one of 
five different concentrations of malathion: 3, 10, 30, 100, 300 ppb, or an ethanol 
vehicle control.  Each treatment was tested in triplicate.  Mortality and water 
quality data (dissolved oxygen, temperature, pH and ammonia concentration) 
	   	   	   	  
 
4	   	   	   	   	  	  
were recorded three times: prior to commencement of exposure, and after 24 
and 48 hours from onset of exposure.  Water quality parameters of exposure 
regimens were not of significant difference.  
Toxicity of the exposure medium used in fish experiments (referred to as 
“malathion spent water”) was confirmed with Daphnia magna (n=10) where 
mortality was assessed at 24 and 48 hours after exposure.  A parallel Daphnia 
toxicity test was performed using medium with freshly mixed malathion from 
original stock at 3, 10, 30, 100, 300 ppb with an ethanol vehicle control; all testing 
was performed in triplicate. Mortality data from both types of Daphnia exposures 
(malathion spent water vs. fresh water) were compared and evaluated for 
significant differences, where none were found.  
 
RNA Isolation 
At 48 hours, fish from each treatment group were collected (by random 
computer-generated assignment), and anesthetized using 0.01g of tricaine 
methane sulfonate (MS-222), (Western Chemical, Ferndale, Washington).  
Individual fish were immediately flash frozen in liquid nitrogen and stored at -80 
°C until retrieval for RNA isolation.  Total RNA was prepared from individuals 
flash-frozen in liquid nitrogen (n=5 per treatment group) and ground to a fine dust 
using pre-baked (at 300 °C) mortars and pestles that were pre-cooled with liquid 
nitrogen directly before use.  Total RNA from each individual was extracted using 
TRIzol reagent as described by the manufacturer (Invitrogen, Carlsbad, CA) 
followed by further homogenization with a Qiashredder kit (Qiagen, Valencia, 
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CA). Total RNA samples were treated with DNase and cleaned using RNeasy 
MinElute Cleanup kits (Qiagen). Pre-cleaned and cleaned RNA samples were 
quantified by spectrophotometer (NanoDrop 1000, Thermo Scientific, Waltham, 
MA) and quality-checked with agarose gel electrophoresis.   
 
Transcriptional analysis  
A salmonid 16K cDNA array was used that was obtained from the 
consortium for genomic research on all salmon project (cGRASP of University 
Victoria, B.C.). The experimental design incorporated the use of a common 
reference (vehicle control) with two-color labeling of pooled samples (n=5 per 
treatment group) and three technical replicates (including one dye-swap) per 
malathion concentration tested (10 ppb, 30 ppb, and 100ppb), resulting in a total 
of nine chips.  Hybridizations were performed using Genisphere 900 (3DNA, 
Hatfield, PA) labeling kits and methods specified by the manufacturer.  For each 
microarray, 2 µg of pooled total RNA from both control and treated samples were 
reverse-transcribed using the supplied oligo primers with 3’ or 5’ unique capture 
sequences (used in the Cy3 or Cy5 labeling reactions, respectively) and reverse- 
transcriptase kit (Invitrogen, Carlsbad, CA).  Microarray slides were prepared for 
hybridization using cDNA in formamide-based hybridization buffer applied to pre-
warmed microarray slides and hybridized overnight (16 h) at 50 °C.  After the 
cDNA hybridization, microarray slides were washed and dried by centrifugation.  
This was followed by the labeling hybridization step performed (3 hours at 50 °C) 
using the Genisphere 3DNA Cy 3 and Cy 5 capture reagents in formamide 
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hybridization buffer. Each of the fluorescent capture reagents hybridize to a 
corresponding capture sequence on the Cy 3 or Cy 5 oligo primers bound to the 
microarray (Cooper et al.).  Post-hybridization washing and drying were 
performed in the same manner as previously detailed (Rise et al. 2004a).   
 
Real-time RT-Quantitative PCR (qPCR)  
Total RNA was reverse transcribed using Affinity Script reverse 
transcriptase (Stratagene, Cedar Creek, TX) as previously performed (Rise et al., 
2004).  Brilliant SYBR Green kits (Stratagene) were used along with two PCR 
primers either for target gene of interest (GOI), or the housekeeping normalizer 
gene Guanine Nucleotide-Binding Protein Subunit Beta-2-Like 1 (GNB2L1, more 
commonly known as RACK 1).  All qPCR primer design and methods followed.  
Each 25 µl qPCR reaction contained diluted template from individual fish (n=5 
per treatment group) and run in duplicate for 40 cycles using a Mx3000p 
(Stratagene) thermocycler.  A standard curve was completed on each plate for 
each gene.  No template controls were included for each reaction. Normalized Ct 
values from malathion-exposed and vehicle control samples were compared 
using Mx3000p software and the relative delta-delta Ct quantification method of 
Pfaffl (2001).  Melting curves for qPCR products were evaluated to show single 
peaks, and end-point agarose gel electrophoresis was performed to show single 
bands of expected size. 
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Microarray analyses 
Microarray slides were scanned using a ScanArray Express (Perkin-
Elmer, Waltham, MA) to acquire fluorescent images with settings of 10 um 
resolution, laser power of 90%, and a wavelength of 543 nm and 633 nm (10 nm 
bandwidth) to excite the Cy 3 and Cy 5 fluorophores, respectively. Fluorescence 
intensity data for each channel were extracted from TIFF images using ImaGene 
7.0 software (Biodiscovery, Santa Monica, CA) and further analyzed in 
Genespring (Agilent, Santa Clara, CA) software; data were background corrected 
and Lowess normalization was applied. LIMMA’s (Linear Models for Microarray 
Data package), found as a part of Bioconductor (http://bioconductor.org), lmFit 
function was used to fit linear models to the gene expression data generated in 
Genespring.  A list of genes showing significant differential expression was then 
generated using a moderated F-statistic and composed a final gene list used in 
all subsequent transcriptomic secondary analysis.  Submission of microarray 
data and experimental design abides by standards set forth according to 
minimum information about a microarray experiment (MIAME) standards 
(Brazma et al., 2001). 
 
Secondary Analysis 
Candidate malathion-responsive genes identified in LIMMA were involved 
in a secondary analysis to include network, cluster, and ontologic analysis. 
Graphic representations of data were generated using the graph and gplot 
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applications of Bioconductor. Gene interaction networks of significantly 
dysregulated genes were generated through the use of igraph open-source 
software package and incorporated the use of the algorithm described by 
Newman (2006).  Network data was visualized using Cytoscape (Shannon et al., 
2003), an open-source bioinformatics software platform for visualizing molecular 
interaction networks. Clustering of dysregulated transcripts was performed using 
agglomerative hierarchical clustering without performing mean centering of 
expression values, and using Ward’s method of merging clusters (Eisen et al., 
1998). 
 
Results 
Malathion 48- hour exposure  
The ability to rapidly determine exposure to dangerous and harmful levels 
of malathion is challenging.  Most studies have focused on malathion toxicity and 
its mechanism of action, yet to the best of our knowledge no studies have 
identified accurate and sensitive transcriptional biomarkers that can be used to 
determine fish health status in exposed environments.  Specifically, malathion is 
highly toxic to all salmonids, of which the most sensitive species include rainbow 
trout, lake trout, brown trout and coho salmon.  Levels as low as 2 ppb (U.S. 
EPA, 2002) cause overt signs of toxicity in rainbow trout, though levels ranging 
from 3-300 ppb (U.S. EPA, 2006; Kahn, 1992; Ando, 1994) are frequently 
reported in lakes and streams located in close proximity to agricultural sites.  
Therefore, we first quantified malathion toxicity to rainbow trout sac fry and swim-
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up fry by using a broad spectrum range of malathion concentrations (3 - 300 ppb) 
at 24- and 48-hour time points. 
Swim-up and sac fry exhibit differential mortality profiles to malathion in a 
dose- and time-dependent manner (Figure 1).  At 24 hours, mortality in swim-up 
fry was not seen at 3, 10 and 30 ppb malathion concentrations, with a slight 
increase to 3% at 100 ppb.  However, mortality dramatically increased to 93% at 
300 ppb. In sharp contrast, sac fry exhibited a small increase in mortality to 3% at 
100 ppb and displayed 0% mortality with all other malathion treatments.  The 
differences in sensitivity between swim-up and sac fry continued at 48 hours, 
specifically in 100 and 300 ppb malathion treatment groups.  We observed a 40% 
mortality in swim-up fry at 100 ppb and 100% at 300 ppb.  Sac fry remained 
relatively resistant to malathion, with a modest mortality of 3% at both 100 and 
300 ppb treatments.  
Qualitative analysis of malathion-induced mortality was positively 
correlated with increased morbidity revealed by the accompanying behavioral 
changes.  We video recorded lethargy (difficulty maintaining an upright position), 
increased respiratory distress, presence of dorsally located mid-tail hematomas, 
and slowed or absent reflex response to tail touch with a forceps (suggestive of 
paralysis).  Morbidity observations were exclusive to the swim-up fry and could 
be detected by 24 hours in 100 and 300 ppb treatment groups.  
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Identification of novel transcriptional biomarkers 
Next, we sought to identify transcriptional dysregulation resulting from 
malathion exposure in the more sensitive life stage of swim-up fry using 
microarray analysis. We identified 349 dysregulated genes at concentrations as 
low as 10 ppb.  Network and enrichment analysis of the microarray data revealed 
changes in expression of wide-ranging ‘high trust’ genes that included small 
ribosomal protein (RPL23A), glucose catabolic process gene (ALDOB), 
glycoprotein metabolism (ST3GAL5) and several transporter genes (G6PT, 
ATP5L, SLCO1B2) (Table 4). As expected, most of the dysregulated genes did 
not exhibit similar expression patterns across broad malathion exposure and time 
points.  Therefore, we used several approaches, including qPCR, cluster, 
ontological and enrichment analyses to identify those genes that consistently 
differed from non-treated controls.  In principle, these consistently dysregulated 
genes may be more suitable biomarkers.  We discovered two compelling genes 
during our analysis that showed consistent dysregulation, cytochrome P4501A 
(CYP1A) and heat shock protein 30 (HSP30) (Figs. 2, 3), warranting further 
investigation.  
We more fully explored the role of CYP1A and HSP30 as potential 
malathion biomarker genes 48 hours after treatment (3, 10, 30, 100 ppb).  We 
quantified transcript expression levels of CYP1A in both sac fry and swim-up fry 
to determine if these were inducible by malathion.  To further investigate this we 
used the CYP1A1 and CYP1A3 paralogs, which share a 96% amino acid identity 
in rainbow trout (Cao et al., 2000), in qPCR analysis. Transcript analysis of 
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CYP1A3 showed a modest, 3.3-fold up-regulation at 100 ppb compared to 
controls (Fig. 2). Interestingly, expression of CYP1A1 did not differ across 
malathion treatment groups or from controls of either life stage, while transcript 
expression levels for both CYP1A1 and CYP1A3 did not differ in sac fry across 
all experimental trials (Fig. 2). 
In looking at the other candidate biomarker HSP30, we quantified 
transcript expression levels in swim-up fry, which showed the greatest change in 
malathion-induced mortality and morbidity.  We observed changes in transcript 
expression levels for all HSP30 paralogs (lettered A-D) analyzed by qPCR, 
where expression was most strongly up-regulated compared to non-treated 
controls in the 100 ppb malathion treatment group.  The most pointed changes 
occurred with HSP30C and HSP30D transcripts, with a dramatic 24.02- and 
46.26-fold increase in expression level, respectively (Figure 3).  These data 
indicate the potential value of HSP30, particularly HSP30C and HSP30D as  
robust biomarkers of malathion exposure in aquatic ecosystems. 
Taken together, our data suggest that the two independent biomarkers 
CYP1A1 and HSP30 can be employed to determine malathion toxicity in 
sensitive rainbow trout swim-up fry. 
 
Network, gene ontology, and cluster analyses suggest additional biomarkers 
Our robust gene expression patterns of HSP30 led us to ask whether we 
could identify genes that change at very low malathion concentrations (≤10 ppb). 
To address this we performed a network analysis of the microarray data, which 
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revealed 26 distinct gene communities.  We followed this using hubness (hub) 
scores to confer network connectivity, community association and biological 
importance of a gene (Table 1). The top 50 genes, based on hub score belonged 
to relatively few (7) communities within the network, suggesting potentially 
identifiable biological pathways in malathion toxicity. Moreover, the direction of 
dysregulation at 10 ppb resulted in 45 down-regulated genes of the 50 total 
highest hub score genes (Table 1). These results suggest that malathion toxicity 
elicits a gene regulatory response at low levels.     
 We then used ontological analysis of the 349 malathion-responsive genes 
used in network analysis, and placed them into biological and molecular 
functional gene ontology (GO) categories (Tables 2, 3).  Biological processes 
most affected by malathion exposure included metabolism (31 genes), oxidative 
stress (11 genes) and signal transduction (20 genes) (Table 2).  Our analysis 
also revealed diverse molecular function categories that included metal ion 
binding (41), catalytic and hydrolase activity (39 genes), cell transport (12 
genes), oxidation-reduction (11 genes) and transferase activity (9 genes).  These 
broad but identifiable changes hold great promise for identification of molecular 
mechanisms of malathion-induced toxicity. 
 
Discussion 
The present study suggests tremendous value in using early life stages of 
fish to identify potentially harmful pollution of both the aquatic environment and 
its derived food sources in human consumption. Specifically, we show that swim-
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up fry are highly sensitive to these environmental changes.  These fish exhibit a 
substantial increase in mortality compared to sac fry and non-exposed controls.  
Importantly, we identified two novel biomarkers expressed in swim-up fry that are 
upregulated within two days of exposure to malathion at 100 ppb.  Our additional 
network analysis suggests that further investigation will yield additional 
biomarkers that can be identified at even lower malathion exposure 
concentrations. 
Observation of early developmental stages of fish have long been used as 
indicators of organophosphate pesticide contamination in water, yet the ability to 
identify robust genomic biomarkers has been relatively non-existent despite the 
potential impacts on humans and wildlife.  Using acute exposure to fenitrothion, 
Hobden et al. suggested that rainbow trout juveniles were most sensitive to 
exposure due to an inability to convert the compound into a benign metabolite 
(Hobden and Klaverkamp, 1977).  Similarly, walleye swim-up fry are highly 
sensitive to low concentrations of chlorpyrifos, where changes in gill structure 
related to age have been suggested as the basis for enhanced sensitivity 
(Phillips et al., 2002).  In agreement with our study, both rainbow trout and 
Japanese medaka (Oryzias latipes) sac fry were the least sensitive to OP 
exposure (Hobden and Klaverkamp, 1977; Takimoto et al., 1987).  The promise 
of using these early stage fish to identify organophosphate exposure highlights 
the need to better identify biomarkers that are concomitantly expressed. 
 The biomarkers (CYP1A3, HSP30C, and HSP30D,) identified in our current 
study are novel for their use in identifying malathion toxicity at lower levels than 
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has been used with AChE inhibition, which has traditionally been employed for 
this purpose. Induced by pesticides in fish, Cytochrome P450 1A (CYP1A) 
enzymes are known to mediate biotransformation of a wide range of xenobiotics 
(Haluzova et al., 2009).  Specifically, cytochrome P450 isoforms (along with other 
flavin-containing monooxygenases) play an influential role in the toxicity of OPs 
since they catalyze the formation of oxon metabolites; malaoxon is the 
bioactivated metabolite of malathion and provides for a dramatically enhanced 
potency of AChE inhibition (Fukuto, 1990).  Separate hydrolytic processes are 
required for detoxification of malathion where AChE remains unaffected 
(Maxwell, 1992).  In the present study, we found CYP1A3 to be inducible in 
swim-up fry but not in sac fry.  This finding suggests the possibility of swim-up fry 
possessing a greater catalytic efficiency of oxon formation, and could explain the 
difference in susceptibility to malathion toxicity between the life stages.  To our 
knowledge, this is the first time that malathion has been reported as an inducer of 
CYP1A3 in trout.  
   
Transcriptional analysis  
In this study we sought to use varied methods of network data analysis to 
provide biologically meaningful insight into malathion-responsive genes.  Several 
gene annotations were found to have both high hub scores and over-
representation among community ontologies supporting their likely involvement 
in malathion toxicity. Moreover, several unifying biological themes were 
represented in these analyses.  Genes encoding metabolism, metal ion 
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homeostasis, oxidation-reduction reactions, ATP binding, proteolysis, apoptosis, 
and neurodevelopment appear to correlate with a distinctive phenotype of subtle 
malathion toxicity.  In combination, many of these processes have been linked to 
neuromuscular disorders as previously mentioned, due to a cellular disturbance 
in energetic processes or homeostasis (including metal ion homeostasis, 
mitochondrial respiration, and lipid metabolism).  
Analyzing malathion-induced dysregulated genes revealed 40 potential 
candidates involved in metal ion binding.  Not only does this present potential 
biomarkers, but it also provides insight into the type of malathion-induced tissue 
damage.  Genes involved in metal ion binding were of specific interest since 
metal ion homeostasis is crucial for proper physiologic function in all living 
organisms.  Genes encoding zinc ion binding activity were most commonly 
represented followed by calcium, iron, copper, and magnesium. These catalytic 
cofactors are required for numerous cellular functions and maintenance activities. 
Loss of metal ion homeostasis has been shown to clinically develop into 
disorders such as retinal degeneration, diabetes mellitus, and neurological 
disturbances (Hellman and Gitlin, 2002; Hochstrasser et al., 2005).  
Organophosphates are known to induce oxidative stress leading to lipid 
peroxidation and DNA single-strand breaks.  Malathion exposure purportedly 
leads to the formation of reactive oxygen species and subsequent induction of 
oxidative stress causing tissue impairment through lipid peroxidation and DNA 
damage (Jomova and Valko, 2011).  Here we found a dramatic upregulation of 
two heat shock protein (HSP) transcripts, HSP30C and HSP30D, following 
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malathion exposure. An upregulation of HSPs correlate with the adaptation to 
stress by reprogramming cellular metabolic activity so as to protect cells from 
further oxidative stress (Parsell and Lindquist, 1993).  These structurally 
conserved proteins are largely considered to be molecular chaperones, 
functioning in proper protein folding and the maintenance of protein homeostasis.   
 In addition to identifying HSP30 paralogs and CYP1A3 as a quality 
candidate biomarker of exposure to malathion and generating a clearer view of 
malathion toxicity at the molecular level, our research contributes to the small 
amount of existing literature that shows age-dependant sensitivity differences 
where an early life stage is far more resilient to toxic exposure compared to a 
later life stage. Here we emphasize that acetylcholinesterase inhibition should 
not be the sole relied upon parameter for the evaluation of toxicity, due the wide 
range of cellular events adversely altered by malathion concentrations below the 
threshold required for AChE inhibition.  Additionally, the lack of data that relates 
AChE inhibition to malathion exposure scenarios of ecologically relevant 
concentrations is problematic and compromises the reliable use of AChE 
inhibition as a primary biomarker of exposure for OP pesticides.  Thus, with the 
ever-expanding use of malathion in standard agricultural practices, we highlight 
the need for more suitable and sensitive biomarkers of malathion exposure.  We 
demonstrated that malathion exposure alters gene expression at concentrations 
as low as 10 ppb, and where such subtle changes potentially precede adverse 
effects on cellular function including metabolism, metal ion homeostasis, 
oxidation reduction, and signal transduction events.  Therefore, a new class of 
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biomarkers in fish expanded beyond AChE, may transform detection methods 
and augment risk assessment in such a way so as to mitigate harmful 
organophosphate exposure leading to health consequences in diverse living 
organisms that use water resources.  
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 Figure 1. Swim-up fry exhibit a greater malathion-induced mortality rate 
compared to sac fry. Rainbow trout sac fry and swim-up fry were exposed to 
malathion for 24 and 48 hours and the percentage mortality recorded. At 100 
ppb, swim-up fry displayed 3% mortality after 24 hours and 40% mortality after 
48 hours. At 300 ppb swim up fry mortality was at 93% at 24 hours and 100% at 
48. Sac fry had substantially lower mortality rates of 3% after both 24 and 48 
hours with 100 ppb, and 300 ppb after 48 hours. All other mortality rates were at 
0%.  Values are reported as mean ± S.E.M. (n = 10). Different letters differ 
significantly (p<0.05) between treatment group or exposure time, and # (p<0.05) 
designates difference between life stage. Significance was determined by a 
repeated-measures 2-way ANOVA and Bonferroni post-test. 
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Figure 2.  Malathion induces cytochrome P4501A (CYP1A) gene expression in a 
life stage-specific and paralog-specific manner. Transcript expression levels of 
CYP1A paralogs (CYP1A1, CYP1A3) were compared from qPCR analysis on 
rainbow trout sac fry and swim-up fry life stages following a 48 h malathion 
exposure. (A) Expression of transcript CYP1A1 was neither induced nor differed 
significantly in sac fry nor swim-up fry treated by malathion.  (B) Swim-up fry of 
the 100 ppb treatment group showed a 3.3-fold up-regulation of CYP1A3 mRNA 
levels compared to non-treated controls after a 48-hour exposure. *(p<0.05) 
indicates a significant difference compared to control (0 ppb), and Δ(p<0.05) 
compared between paralogs CYP1A1 and CYP1A3, and  #(p<0.05) compared 
between life stages. Values are expressed as mean ± SEM (n = 5). Significance 
was determined by repeated-measures 2-way ANOVA and Bonferroni post-test. 	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Figure 3. The candidate biomarker HSP30 transcript expression levels are 
dramatically upregulated in swim-up fry exposed to 100 ppb malathion.  Relative 
gene expression of four HSP30 paralogs (A-D) was measured by qPCR, in 
rainbow trout swim-up fry following a 48 h malathion exposure. Swim-up fry of 
the 100 ppb treatment group show a 24-fold up-regulation of HSP30 C, and 46-
fold up-regulation of HSP30 D transcript levels compared to non-treated controls.  
Values are expressed as mean ± SEM (n = 5). *(p<0.05) indicates significant 
difference compared to control (0 ppb), whereas ∆(p<0.05) indicated a significant 
difference between paralogs. Significance was determined by a repeated-
measures 2-way ANOVA and Bonferroni post-test. 
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Figure 4. Dynamic expression cluster patterns (9), of genes dysregulated by 
malathion in 48-hour exposed swim-up fry; 349 dysregulated genes were 
identified by microarray for 10, 30, and 100 ppb malathion treatment groups. The 
number of genes that correspond to each cluster is shown in the bottom right 
corner. Clusters numbered 1-3 are highlighted by a red box due to being the only 
expression patterns represented among high hubness score genes (top 50 
genes with highest hubness scores of network analysis).  
 
 
 
 
 
 
10 30 100
-6
-4
-2
0
2
4
6
46 genes
1
10 30 100
-6
-4
-2
0
2
4
6
R
e
la
ti
v
e
 f
o
ld
 c
h
a
n
g
e
 (
lo
g
2
)
4
22 genes
10 30 100
-6
-4
-2
0
2
4
6
7
34 genes
10 30 100
2
40 genes
Malathion concentration (ppb)
10 30 100
5
37 genes
Malathion concentration (ppb)
10 30 100
8
34 genes
Malathion concentration (ppb)
10 30 100
3
62 genes
10 30 100
6
33 genes
10 30 100
9
41 genes
Figure 4
	   	   	   	  
 
22	   	   	   	   	  	  
 
 
 
 
 
 
 
 
Table 1. 50 highest hubness score genes (of network analysis) dysregulated by malathion in rainbow trout swim-up fry.   
Accession #/Gene Name Hubness Score Community Cluster # 10 ppb 30 ppb 100 ppb 
CB496918 60S ribosomal protein L23a 1.00 1 1 -1.07 1.44 2.60
CA053629 Glucose-6-phosphate translocase 0.95 24 3 -2.22 -1.12 1.94
CB497649 Nucleoside diphosphate kinase B 0.82 1 1 -1.25 1.56 4.35
CB497960 Rainbow trout (S.gairdneri) cytochrome P450IA1 mRNA, complete cds 0.79 1 3 -1.90 1.78 4.07
CA058532 UNKNOWN 0.74 1 1 -1.10 1.05 3.58
CB497826 Collagen alpha-3(VI) chain precursor 0.73 1 1 -1.02 1.44 3.24
CK990568 Protein S100-A1 0.70 1 2 -1.31 -1.42 3.08
CA059260 UNKNOWN 0.68 1 1 -1.79 1.19 3.67
CA054628 UNKNOWN 0.68 1 2 -1.32 -1.29 7.75
CB509793 CDC5L, KIAA0432, PCDC5RP: Cell division cycle 5-like protein 0.63 1 3 -1.60 2.56 8.14
CA058261 Beta-sarcoglycan 0.62 25 3 -2.52 1.18 1.99
CB494032 Carbonic anhydrase 0.61 1 3 -2.29 1.48 3.65
CK990774 UNKNOWN 0.60 22 2 1.02 1.06 6.16
CB506607 liver-expressed antimicrobial peptide 2 isoform A precursor 0.58 25 3 -4.71 1.31 2.33
CA062887 Cysteine and glycine-rich protein 1 0.56 1 3 -1.27 1.99 2.70
CB492677 Cyclin-L1 0.56 25 3 -1.90 1.27 2.68
CK991122 Heat shock protein 30 0.56 1 1 1.18 2.73 17.64
BU965792 Myosin heavy chain, fast skeletal muscle 0.55 1 3 -1.30 2.66 5.66
CB511687 Ceruloplasmin precursor 0.55 1 2 -1.06 -1.89 5.85
CA063484 F-box only protein 46 0.54 25 3 -1.31 1.75 4.12
CB518072 Ubiquitin 0.54 22 2 -1.18 -1.50 2.79
CA063520 Signal peptide peptidase-like 2A 0.54 1 1 -2.69 -1.26 6.40
BU965792 Myosin heavy chain, fast skeletal muscle 0.54 21 1 -1.99 -1.49 2.50
CA054279 UNKNOWN 0.53 21 1 -1.30 1.51 5.48
BU965780 Integral membrane protein 2B 0.53 1 2 -1.96 -2.92 7.27
CA044571 Salmo salar caspase 3B gene, complete cds 0.53 1 3 -1.65 2.53 4.11
CA059497 AN1-type zinc finger protein 2B 0.50 24 1 -2.86 -2.00 -2.33
CA054811 Solute carrier organic anion transporter family member 1B2 0.49 24 3 -1.27 2.01 4.86
CB488319 Uncharacterized protein C8orf76 0.48 21 1 -1.88 -1.10 2.63
CB514220 ATP synthase subunit g, mitochondrial 0.48 24 3 -14.10 1.45 3.51
CA057297 G-rich sequence factor 1 0.45 24 3 -4.56 -1.00 2.45
CA050885 Cleavage and polyadenylation specificity factor 6 0.45 22 1 -1.44 1.22 5.14
CA061046 UNKNOWN 0.43 18 2 1.27 1.07 3.02
CA050836 UNKNOWN 0.42 18 2 -2.14 -2.54 2.05
CB492951 DNA-binding protein inhibitor ID-2 0.42 24 3 -3.00 1.43 4.47
CA045746 Actin, cytoplasmic 1 0.41 25 3 -2.58 1.65 2.61
CA038556 Tumor suppressor candidate 4 0.41 18 1 -1.09 1.10 5.37
CA061907 UNKNOWN 0.40 24 3 -2.36 1.11 -1.47
CB492545 Transcription factor HES-1 0.39 1 1 -1.19 1.21 5.98
CA064263 U6 snRNA-associated Sm-like protein LSm8 0.39 1 2 -1.08 -1.13 16.61
CB492414 T-complex protein 1 subunit delta 0.39 21 1 1.08 1.54 2.57
CB489812 Oncorhynchus kisutch 5S ribosomal RNA gene, partial sequence 0.37 1 2 -2.05 -2.39 2.60
CB509708 Ferritin, heavy subunit 0.36 21 1 -1.92 1.11 3.55
CB515915 Lactosylceramide alpha-2,3-sialyltransferase 0.35 22 1 -2.39 -1.49 2.58
CA063464 UNKNOWN 0.33 21 3 -3.50 1.46 6.35
CA058089 Probable arylformamidase 0.33 1 2 1.21 1.19 5.54
CB492432 UNKNOWN 0.33 21 1 -1.60 -1.40 3.92
CB493026 Thioredoxin 0.32 19 1 -1.43 -1.00 3.23
CA767684 H-2 class II histocompatibility antigen gamma chain 0.31 18 2 -1.27 -1.39 2.68
CA061400 COP9 signalosome complex subunit 2 0.31 22 1 -1.45 -1.22 3.29
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Table 2. Biological process gene ontologies described for 349 genes identified by microarray.
GO1 Biological Process (BP) Term GO ID # # Genes2
Metabolism GO:0044237 31
Response to Stimulus GO:0050896 22
       Stress response GO:0033554 11
Signaling/Signal transduction GO:0023052 20
Anatomical structure development GO:0048856 16
Transport GO:0006810 13
Transcription GO:0045449 11
Apoptosis GO:0006915 10
Cell differentiation/cell cycle GO:0030154 10
Immune system GO:0006955 9
Cell adhesion GO:0007155 7
Neurological GO:0050877 7
Cell proliferation GO:0008283 6
Homeostasis GO:0033554 6
Cytoskeleton organization GO:0007010 6
Proteolysis GO:0006508 6
Translation GO:0006412 5
Ribosome GO:0042254 5
Cell migration GO:0016477 3
Developmental process GO:0032502 3
Oxidation-reduction GO:0055114 3
1 GO= gene ontology of biological process classification described on website: http://www.geneontology.org/
2 Number of genes refers to the number out of 349 genes (identified by microarray analysis and found to be
significant using a combined p value, p <0.05) described by the listed GO BP term and GO ID #. 
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Table 3. Molecular function gene ontologies described for 349 genes identified by microarray.
GO1 Molecular Function (MF) Term GO ID # # Genes2
Protein binding GO:0005515 52
Nucleic acid binding GO:0003676 51
Metal ion binding total GO:0046872 41
          Calcium GO:0005509 9
          Zinc GO:0008270 18
          Copper GO:0005507 3
          Iron GO:0008199 6
          Magnesium GO:0000287 2
         Other metal (unspecified) GO:0046872 3
ATP binding GO:0005524 17
Receptor binding activity GO:0004872 3
Catalytic/hydrolase activity GO:0003824 39
Transport GO:0005215 12
Oxidation-Reduction GO:0016491 11
Transferase activity GO:0016740 9
Ribosome GO:0003735 6
Peptidase activity GO:0008233 5
Signal-Transduction GO:0004871 5
Cell cycle GO:0007049 4
Transcription GO:0030528 4
Enzyme inhibitor GO:0004857 3
Protein Dimerization GO:0046983 3
1 GO= gene ontology classes of molecular function and  described on website: http://www.geneontology.org/
2 Number of genes refers to the number out of 349 genes (identified by microarray analysis and found to be
significant using a combined p value, p <0.05) described by the listed GO MF term and GO ID #. 
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Table 4. GO terms found to be enriched within network communities (having >10 members).  
Community ID Ontology GO ID GO Term P Value # Genes Total Genes/Comm
1 MF1 GO:0003774 motor activity 0.012 2 33
1 MF GO:0005198 structural molecule activity 0.049 3 33
3 MF GO:0008233 peptidase activity 0.018 6 39
4 MF GO:0016491 oxidoreductase activity 0.038 4 43
4 BP2 GO:0044281 small molecule metabolic process 0.048 5 43
16 BP GO:0044255 cellular lipid metabolic process 0.032 3 43
16 MF GO:0008234 cysteine-type peptidase activity 0.023 2 43
16 BP GO:0061024 cell membrane organization 0.026 2 43
18 BP GO:0043170  macromolecule metabolism 0.016 7 21
18 MF GO:0022857  transporter activity 0.027 2 21
21 BP GO:0006091 generation of precursor metabolites and energy 0.018 2 12
22 BP GO:0043170 macromolecule metabolism 0.003 4 18
24 MF GO:0005215  transport activity 0.001 4 21
1MF=Molecular Function
2BP=Biological Process
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Chapter 1.  
Extended Thesis Introduction 
Malathion (1,2-di(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate) 
is a chemical compound classified as an organophosphate (OP) broad spectrum 
insecticide with widespread use. It is commonly employed in agricultural practice 
as a pesticide, in public health sanitation efforts for pest eradication (such as 
those aimed at mosquito abatement, boll weevil eradication, and medfly control), 
and in residential use as a herbicide/fungicide. Estimated annual application in 
the U.S. is approximated 16.7 million pounds, where 12.5 million pounds are 
applied exclusively to food crops (ATSDR, 2003). Consequently, a high 
probability of contamination exists for aquatic habitats in close proximity to 
agricultural land due to pesticide run-off and infiltration of ground water.  
According to the U.S. EPA, malathion poses a moderate to high toxicity in 
fish species; specifically, rainbow trout show extreme sensitivity to exposure and 
correspond to a 96-h LC50 of 4 ppb (U.S. EPA, 2000).  While limited data are 
available for malathion concentration levels of specific freshwater environments, 
water concentrations as high as 583 ppb have been reported to occur 
downstream from agricultural application sites and have resulted in fish-kills 
(Ando, 1994). More recently, the National Marine Fisheries Service (NMFS) 
investigated registered malathion usage (as established by EPA Registration 
Eligibility Decision, 2006) and the degree of exposure risk on 28 Pacific salmonid 
species. NMFS concluded that registered malathion usage would jeopardize the 
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continued existence of 27 Pacific salmonid species, and destroy or adversely 
modify critical aquatic habitat (NMFS Biological Opinion, 2008). Thus, prevalence 
of malathion contamination in biologically significant amounts is of extreme 
relevance and poses potential hazards for freshwater eco-systems.   
While malathion is highly effective as a multi-use OP insecticide, concern 
arises due to it’s indiscriminate mode of action via acetylcholinesterase inhibition 
in both target and non-target specie (Chambers and Carr, 1995).  AChE is 
essential for cholinergic neurotransmission and functions to catalyze the 
hydrolysis of the neurotransmitter acetylcholine (Ach).  Malathion acts to target 
the enzyme AChE with the resultant effect of ACh accumulation, subsequent 
overstimulation of cholinergic receptors, and ensuing excitotoxicity. Sustained 
high levels of AChE inhibition induced by acute exposure to an organophosphate 
such as malathion, can disturb function of both the central and peripheral 
nervous systems. In humans, symptoms of acute OP poisoning are dependent 
upon severity and length of exposure, but often include respiratory failure, 
muscle spasms, and mental confusion (Haque et al., 1987; Sweeney and Lyon, 
1999). In severe exposures, coma and death can result (Warren et al., 1985). In 
fish, aberrant behavior associated with acute toxicity may include erratic 
swimming, hyper- excitability, loss of equilibrium, and caudal bending (Patil and 
David, 2010). Such behavioral alterations adversely affect fish performance and 
survival.  
It is well accepted that malathion-induced neurotoxicity is primarily elicited 
via inhibition of acetylcholinesterase; however, malathion exposure elicits 
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toxicologically relevant noncholinergic outcomes even at concentrations that are 
below the threshold for AChE inhibition. Malathion has pro-oxidative properties 
(Banerjee et al., 1999) capable of eliciting lipid peroxidation in rodent 
erythrocytes, liver and brain tissues (Hazarika et al., 2003).  Malathion-induced 
oxidative stress also suppresses anti-oxidant enzyme expression, and has 
demonstrated ability to damage DNA of rat hippocampal tissue (Brocardo et al., 
2007; Franco et al., 2009). In vitro studies have demonstrated noncholinergic 
concentrations of malathion initiate apoptosis via caspase-dependant pathways 
(Masoud et al., 2003). In contrast, malathion also exerts mitogenic effects at low 
levels in vitro (Moore et al.).  Collectively, these studies support the idea that 
toxicological action of malathion does not arise solely from the inhibition of AChE, 
while emphasizing the importance of considering additional molecular targets of 
action. The noncholinergic effects of OPs have received significantly renewed 
attention in the scientific literature. However, few recent publications focus on the 
identification of additional mechanisms of toxicity for low-dose malathion 
exposure. Moreover, few publications explore how gene expression is altered by 
malathion and the corresponding biological implications of such alterations.  
In the present study, we directed our efforts toward gaining insight into the 
molecular consequences of low-level exposure using rainbow trout as a model 
system. We were able to accomplish this objective through analysis of differential 
gene expression assessed by microarray. Malathion-responsive genes were 
identified from two distinct early developmental stages of rainbow trout fry at 
environmentally relevant concentrations. The objective of this study was to 
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identify candidate biomarkers of exposure to malathion, while deriving biological 
meaning from induced gene expression alterations in rainbow trout. The present 
study aims to improve our understanding of the molecular basis for malathion 
induced physiologic dysfunction apart from acetylcholinesterase inhibition. The 
establishment of malathion-induced transcriptional biomarkers could improve and 
transform current wildlife health risk assessment practice by allowing for early 
detection and quantification of toxic exposure in aquatic environments. 
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Appendix 
Transcriptional analysis 
Analyzing the GO functions associated with the genes that were 
dysregulated by malathion revealed 40 genes involved in metal ion binding. 
Genes involved in metal ion binding were of specific interest since metal ion 
homeostasis is crucial for proper physiologic function in all living organisms. 
Genes encoding zinc ion binding activity were most commonly represented 
followed by calcium, iron, copper, and magnesium. Metal ions such as zinc, iron, 
copper, and magnesium play roles as catalytic cofactors to a variety of 
metalloproteins and enzymes that are required for numerous cellular functions 
and maintenance activities. Zinc and copper are capable of modulating gene 
expression through interference of signal transduction pathways and have the 
capacity to activate transcription factors involved in cell cycle progression and 
apoptosis (Evan and Vousden, 2001). Similarly, calcium is a cell signaling 
molecule integral to signal transduction pathways as a secondary messenger. 
Metal ion homeostasis is a tightly regulated event vital for tissue health, where 
disruption negates such status through impairment of cell viability. Loss of metal 
ion homeostasis has been shown to be causative in a wide range of disease 
including cardiac arrhythmia, myocardial infarction, and chronic 
neurodegeneration (Stohs and Bagchi, 1995; Valko et al., 2005). Disruption of 
metal ion homeostasis could result in dramatic physiologic effects following 
exposure to malathion exposure.   
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Not surprisingly, metal ion binding (specifically zinc, iron, and copper) 
genes were well represented among the top 50 hubness (hub) scores (Table 1).  
Carbonic anhydrase 1 (CA 1, hubness score = 0.61) utilizes zinc as a co-factor 
while promoting osteoclast differentiation and bone resorption. Defects in the 
gene CA 1 often cause ostepetrosis, a disease characterized by abnormally 
dense bone due to disrupted resorption of immature bone.  Cysteine and glycine-
rich protein 1 (CSRP1) is involved in zinc ion binding (hub score = 0.56) and 
potentially plays a role in neuronal development (Swiss Prot).  Cerulosplasmin 
(CP, hub score = 0.55) is known to be involved in both copper metal ion binding 
and cellular iron homeostasis via ferroxidase activity. Defects in CP are 
responsible for iron metabolism disorders that potentially lead to iron 
accumulation in brain tissue and other visceral organs; clinical manifestations of 
such disorders include retinal degeneration, diabetes mellitus, and neurologic 
disturbances (Hellman and Gitlin, 2002; Hochstrasser et al., 2005). Additionally, 
Hochstrasser (2005) and colleagues suggest that altered CP activity caused by 
gene mutation may play a role in neurodegeneration (as exhibited in Parkinson’s 
disease), due to iron-induced oxidative injury to the brain.  
Remaining genes that encode metal ion binding proteins identified by high 
hubness scores included ZFAND2B and ferritin heavy subunit. Ferritin heavy 
subunit is important for cellular iron ion homeostasis and plays a role in immune 
response and negative regulation of cell proliferation. Defects in ferritin proteins 
have been shown to be associated with neurodegenerative diseases (Bush and 
Tanzi, 2008; Huang et al., 2004; Jiang et al., 2009). Ferritin in included under the 
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GO terms category of oxidoreductase activity (Tables 2, 3) and was found to be 
significantly over-represented in network community 21 (Table 4).  This allows us 
to consider that other genes of community 21 could potentially share involvement 
in the oxidoreductase pathway. The network and gene ontology analyses 
strongly indicate that metal ion binding is altered by malathion exposure where 
normal physiology is dramatically impaired. 
In order to maintain a holistic view of physiologic response, it is important 
to consider potentially related functional categories of responsive genes. It is not 
surprising that genes associated with the GO category of oxidation-reduction 
responded to malathion exposure. It has been recently reported that disruption of 
metal ion homeostasis (related to redox homeostasis), may be responsible for 
formation of reactive oxygen species and subsequent induction of oxidative 
stress, causing tissue impairment through lipid peroxidation and DNA damage 
(Jomova and Valko, 2011). Similarly, malathion metabolism has been reported to 
cause oxidative damage. 
It has been shown that zinc attenuates malathion-induced ‘depressant 
behavior’ and affords a neuroprotective effect in the brain (Brocardo et al., 2007). 
This study investigated the imbalance of antioxidant status of the brain, liver, and 
red blood cells after rats were exposed to concentrations of malathion below the 
threshold for acetylcholinesterase inhibition. Malathion is considered to have a 
pro-oxidant effect; however, zinc has been shown to play a crucial role in 
affording protection against oxidative damage by attenuating lipid peroxidation 
(Brocardo et al., 2007).  
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Malathion exposure induced several genes associated with oxidation and 
reduction activities (see Table 3). Organophosphates are known to induce 
oxidative stress leading to lipid peroxidation and DNA-single strand breaks. 
Genes having the biological process gene ontology ‘response to stimulus’ 
comprised the second largest category elicited by malathion exposure (Table 2). 
Interestingly, half of the genes involved in ‘response to stimulus’ specifically 
functioned in stress response, which includes oxidative stress as a sub-category.  
Several heat shock proteins (HSPs) are expressed at elevated levels 
under a wide variety of stress conditions. HSPs support the adaptation to stress 
by reprogramming cellular metabolic activity so as to protect cells from further 
oxidative stress (Parsell and Lindquist, 1993). For this reason, heat shock 
proteins and response are sometimes referred to as ‘stress proteins’ and ‘stress 
response’ in literature. Heat shock proteins are structurally conserved and have 
been identified in both prokaryotic and eukaryotic organisms indicating a 
potentially crucial role in cellular physiology and response to stress. HSPs are 
considered to be molecular chaperones and function in proper protein folding and 
the maintenance of protein homeostasis of the cell. HSP families are designated 
by their deduced molecular mass in kilodaltons. The most commonly studied 
HSPs are HSP90, HSP70, HSP65, and HSP27.  The family of small heat shock 
proteins (sHSPs) is defined as comprising a molecular mass of 15-30 KDa that 
contain a highly conserved region of approximately 90 amino acid residues in the 
C-terminal region.  sHSPs have been identified in both in-vitro and in-vivo studies 
as molecular chaperones where they bind unfolded proteins, suppress 
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aggregation, and promote refolding of proteins to their functional state. Small 
HSPs are inducible and increase tolerance to cytotoxic stressors.  
Small heat shock protein 30 (HSP30) genes were found to be the most 
highly up-regulated genes in our microarray experiments. Probes for two Hsp30 
paralogs were present on the microarray (HSP30A and HSP30B) and two 
additional paralogs were subsequently identified (HSP30C, HSP30D). 
Expression levels for all four paralogs were examined by qPCR (Figure 3). Of the 
HSP paralogs investigated, HSP30C and HSP30D showed strong induction of 
gene expression at the highest concentration of malathion with HSP30D up-
regulated >45 fold. This suggests that both genes are strong candidate 
biomarkers for exposure to high environmentally relevant malathion 
concentrations. This is a novel finding since HSP30  has not been identified in 
fish as a potential biomarker of exposure to any stressor. 
According to the literature, chronic exposure to malathion has been 
observed to be associated with metabolic disorders (Montgomery et al., 2008) 
and genes associated with GO terms related to metabolism were the largest 
category of dysregulated genes. In terms of gene expression, one study found 
that ‘sub-threshold levels’ of malathion suppressed the gene encoding for 
hypothalamic corticotropin-releasing hormone (CRH) in Wister rats (Rezg, 2008). 
CRH is the primary neurohormone that regulates the hypothalamic-pituitary-
adrenal (HPA) axis that influences lipid and carbohydrate metabolic pathways. 
Rezg (2008) compared the malathion induced suppressed hypothalamic CRH 
expression to the diabetes mellitus model of CRH expression. It is suggested by 
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both Rezg (2008) and Montgomery (2008), that chronic exposure to malathion 
(even at sub-threshold levels) is responsible for alteration of metabolic events 
that potentially result in a significantly increased risk for the development of type 
II diabetes (Rezg, 2008; Montgomery, 2008). Malathion has also been found to 
alter expression of genes involved in mitochondrial metabolism, specifically 
cytochrome c I and III (Salazar et al., 2007).  
Glucose-6-phosphate translocase had the second highest hubness score 
(0.9458) out of the 349 genes analyzed and functions in glucose homeostasis. 
Defects in the glucose-6-phosphate translocase gene result in glycogen storage 
disease, biochemical abnormalities such as hypoglycemia and hyperlipidemia, 
and kidney enlargement.  Fructose-bisphosphate aldolase B (hub score = 0.536) 
is involved in glycolysis where defects cause fructose intolerance and 
hypoglycemia. 
Another well-represented category of biological process gene ontology is 
anatomical structural development. COL6A3 (hub score = 0.733) is a cell- 
binding protein, and functions in several areas of structure development that 
include involvement in axon guidance and muscle organ development. Defects in 
the COL6A3 gene in humans may result in Bethlem myopathy or Ulrich 
congenital muscular dystrophy (Lampe and Bushby, 2005), both of which are 
characterized by muscle weakness and early childhood onset of joint 
contractures (Demir et al., 2002; Jobsis et al., 1999).  ID2 T (hub score = 0.417) 
is a transcription regulator (Sun et al., 1991) that plays many roles in the cell 
including the negative regulation of neuronal differentiation, leukocyte 
	   	   	   	  
 
36	   	   	   	   	  	  
differentiation, and osteoblast formation (Swiss prot www.expasy.com).  ID-2 is a 
positive regulator of smooth muscle cell proliferation and astrocyte differentiation. 
DNA-binding protein inhibitor is also involved in digestive tract formation and 
morphology, as well as lymph node development.  Unrelated to these functions, 
ID-2 also plays a role in the synchronization of circadian rhythms to 
environmental cues (such as light). 
Still, other anatomical structural development genes that were found to be 
dysregulated (but do not possess high hubness scores) include those that 
regulate skeletal muscle development (prostate stem cell antigen precursor-like 
gene); limb development (transcription factor Sp8); cardiac muscle morphology 
(bifunctional protein NCOAT); and brain, retina and lens development (ceroid-
lipofuscinosis neuronal protein 5).  Defects in the CLN5 gene result in 
neurodegeneration and are clinically characterized by seizures, dementia, visual 
loss, and cerebral atrophy. Lastly, the anatomical development GO category 
included several genes outside of the top 50 highest hubness scores that all 
function in angiogenesis and include: collagen alpha-1(XV) chain precursor, 
CpG-binding protein, glutamyl aminopeptidase (where two separate features on 
the microarray representing this gene were both found to be dysregulated), and 
focal adhesion kinase 1. Focal adhesion kinase 1 has several functional 
annotations in addition to angiogenesis that include negative regulation of neuron 
axonogenesis, signal transducer activity, and cytoskeleton development. 
Interestingly, focal adhesion kinase has additionally been found to be involved in 
hepatic cell proliferation and induction of hepatic cell apoptosis via the caspase-3 
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pathway (Zhang, XL, 2008). This is important to note since in the present study, 
the caspase-3B gene is among the top 50 highest hubness score (hub score: 
0.525) genes, and apoptosis is represented as a category of BP GO terms (Table 
2) mentioned below.  
 Genes having roles in apoptosis and found to be among dysregulated high 
hubness score genes include caspase 3B, integral membrane protein 2B, tumor 
suppressor candidate 4, and thioredoxin. Aside from apoptosis, caspase 3B is 
thought to be involved in cleavage of amyloid-beta 4A precursor protein, and 
associated with neuronal death in Alzheimer’s (Swiss prot). Thioredoxin 
specifically possesses an anti-apoptotic functional role and is potentially involved 
in resistance to anti-tumor agents (Chen et al., 2002), while also playing a role in 
mitochondrial membrane potential (Damdimopoulos et al., 2002). Consistent with 
our findings, previous studies report apoptosis following organophosphate 
exposure. For example, an in vitro study that described the effects of malathion 
exposure at non-cholinergic doses, demonstrated activation of caspase 3 protein 
expression and suggests that cytoxicity of malathion is mediated through 
caspase-dependent apoptosis (Masoud et al., 2003). Another study that related 
apoptosis to OP exposure reported alteration of cell cycle events, proliferation, 
and cell death just one hour after an initial acute exposure to soman (Dillman et 
al., 2009).  Additionally, apoptosis has been cited as a non-genomic biomarker of 
effect in rats exposed to the OP pesticides malathion and chlorpyrifos (Aluigi et 
al., 2005).  
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Several communities in the network were enriched for genes with specific 
functional annotations such as proteolysis, ATP binding, metal ion binding, 
oxidoreductase activity, apoptosis, cell cycle, metabolism, neurological function, 
immune response, protein synthesis and cytoskeletal organization (Table 4). 
Derivation of biological functions from enrichment analysis required investigating 
cellular role and disease involvement of individual genes per community (comm). 
To begin, two genes encoding for myosin heavy chain, and two ribosomal genes 
(RPL23A & RPL19) were found to be over-represented in comm 1 and were 
additionally among high hub score genes displayed in Table 1. While it was 
expected that motor activity genes would be responsive in acetylcholinesterase 
inhibition, the enrichment status of the gene encoding a small ribosomal protein 
(RPL23A) and 1st place listing (hub score =1.0) amongst other high hub scores 
seemed puzzling. However, of recent, ribosomal proteins have garnered 
appreciation outside of their predominant role in protein synthesis.  The literature 
contains studies that suggest RPL23A potentially plays a role in drug clearance 
via participation as a drug carrier protein (Dinman, 2007). Interestingly, RPL23A 
has also been implicated in conferring drug resistance due to interaction with p53 
and subsequent apoptotic suppression (Singh, 2006).   
Four of six genes responsible for comm 3’s enrichment status were found 
to play a role in both proteolysis and metal ion binding activity. Of particular 
interest was the gene TPP1, due to participation in lipid metabolic processes, 
zinc metal ion binding, and nervous system development (Table 4). Defects in 
TTP1 have been documented to be the cause of neuronal ceroid lipofuscinosis 
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type 2, a neurodegenerative lysosomal storage disease characterized by 
seizures, dementia, visual loss, and/or cerebral atrophy. Also found in comm 3 
was ROM 4, a gene that encodes for protease activity, but additionally acts to 
control apoptosis by preventing release of mitochondrial cytochrome c, which 
would otherwise respond to apoptoptic signals.  
In community 4, five genes associated with over-represented annotations 
are involved in calcium ion homeostasis, ATP binding and/or regulation of 
ATPase activity, and zinc ion binding. Of those linked to disease, bifunctional 
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) 
plays an essential role in early development by providing for cell adhesion, signal 
transduction and ATP binding, although it is also involved in tumorigenicity and 
metastatic behavior of malignant cells. Interestingly, a defect in GNE provides for 
metabolic defects that often result in sialuria a disease that induces 
developmental delay of variable degrees. GNE defects can also cause body 
myopathy type 2, a neuromuscular disorder affecting the leg muscles.  
GTPase KRas (KRAS) is also a gene of comm 4 with over-represented ontology 
status that participates in the activation of MAPKK activity, Ras protein signal 
transduction, and axon guidance. Defects in this gene have been shown to be a 
cause of acute myelogenous leukemia, characterized by cardiac anomalies, 
deafness, motor delay, and also gastric cancer. Furthermore, KRAS gene 
defects have been shown to cause glial cell derived tumors of the brain and 
spinal cord with the potential to be malignant. Lastly, the disease cardio-facio-
cutaneous syndrome (CFS) is the result of defects in the KRAS gene and is 
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associated with heart defects (such as cardiomyopathy and atrial septal defects) 
and mental retardation.  
Community 16 genes of enrichment status include proactivator 
polypeptide (PSAP) which is involved in lipid metabolism. Gene defects in PSAP 
cause a fatal lipid storage disorder, and consequent severe neurologic 
dysfunction. Furthermore, PSAP gene defects are also responsible for the 
disease Krabbe, a disorder of galactosylceramide metabolism characterized by 
progressive encephalopathy and abnormal myelination in the cerebral white 
matter. A second gene, UNC13D, regulates excocytosis in lymphocytes. 
Intercepted gene function of UNC13D elicits immune system dysregulation, while 
a range of clinical manifestations may be exhibited including neurologic 
abnormalities such as seizures, cranial nerve deficits, and ataxia. Yet, another 
community 16 gene that functions in lipid transport and apoptosis encodes for 
cell death protein 6 homolog (CED6). CED6 may play an additional role in 
providing for internalization and endosomal trafficking of the previously 
mentioned proactivator polypeptide (PSAP); this suggests that communities may 
be partitioned into functionally related, co-expressed gene groups. Lastly, 
prostate stem cell antigen (PSCA) of comm 16 is a proteolytic enzyme, 
dependant on zinc or calcium metal ions for it’s catalytic mechanisms. In the 
brain, PSCA provides a critical role in modulation of excitatory 
neurotransmission. However, there is literature support for PSCA having a role in 
cell proliferation regulation (Sakamoto, 2010). PSCA is used often as a 
diagnostic indicator of prostate cancer, but has additional use as a marker for 
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neurological disorders such as schizophrenia, Alzheimer’s, and Huntington 
disease. 
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1) 
is a gene of enrichment status and interest community 18. The main role of 
SLC2A1 lies in regulation of insulin secretion. Defects in this gene directly cause 
defective blood-brain barrier glucose transport and induced neurologic disorders. 
The prevalent phenotype displayed in these severe neurologic disorders includes 
epileptic encephalopathy associated with delayed development, uncoordinated 
motor ability, and spasticity. Additionally, SLC2A1 defects cause a range of 
cognitive impairment spanning the onset of learning disabilities to severe mental 
retardation. Additional clinical symptoms indicative of defects in this glucose 
transporter gene include ataxia, confusion, lethargy, sleep disturbance, and 
headaches. Lastly, the disease GLUT1 deficiency syndrome type 2 
(GLUT1DS2), is also caused by SLC2A1 gene defects featuring abnormal 
involuntary movements of the limbs, epilepsy, and/or mild mental retardation.  
Four genes of community 21 associated with over-represented ontologies 
include involvement in oxidoreductase activity, gluconeogenesis, ATP binding, 
and iron ion homeostasis. Amongst these is NADH-ubiquinone oxidoreductase. 
Of important note is this gene’s role in mitochondrial respiration and electron 
transport. Gene defects are associated with mitochondrial respiratory chain 
disorders and are the basis of many prevalent neurodegenerative diseases such 
as Parkinson’s. Observed phenotypes include encephalopathy, cardiomyopathy, 
myopathy, liver disease, Leber hereditary optic neuropathy, and Parkinson’s 
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disease variations. Most notable is the fact that 3 of the 4 enriched comm 21 
genes also possess high hub scores.  
Community 22 genes that hold enrichment status include 26S proteasome 
non-ATPase regulatory subunit 8 (PSMD8) known to be involved in the apoptotic 
process and DNA damage response, the gene properdin (involved in innate 
immunity), and high hub score gene lactosylceramide alpha-2,3-sialyltransferase 
(ST3GAL5)  involved in glycosylation. Defects in ST3GAL5, are known to be the 
cause of infantile epilepsy syndrome characterized by developmental stagnation 
and blindness.  
The gene encoding thioredoxin-interacting protein is of community 24, and 
involved in both innate immune response and suppression of tumor cell growth 
through transcriptional repression. Glucose-6-phosphate translocase (part of the 
solute carrier family, SLC37A4) of comm 24 and also corresponds to a high hub 
score, is part of the solute carrier family and central to cellular blood sugar 
homeostasis by gluconeogenesis involvement. The 3rd gene of comm. 24 is ATP 
synthase, (involved in the catabolic process of ATP and maintaining proper 
mitochondrial membrane potential) which also corresponds to a high hub score 
(Table 1). Notably, impaired mitochdrial respiration caused by decreased ATP 
production, has been reported in neurodegenerative diseases such as 
parkinson’s. ATP synthase mutations cause mitochondria dysfunction where 
neuromuscular impairment is exhibited (Kim, 2011). Loss of ATP synthase 
activity is followed by muscle degeneration and accumulation of tubulin protein; 
previous studies show this to be the equivalent of the parkin mutant phenotype 
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(Celotto, 2006; Mayr, 2010).  
Finally, community 25 genes of enrichment status include actin-like protein 
3 (involved in ATP and actin binding, while also involved in ciliogenesis), and 
beta-sarcoglycan (SGCB) involved in cytoskeletal development. Of functional 
interest, is the relationship between SGCB gene defects and muscular dystrophy 
type 2E, where muscles of the limbs and pelvic girdle are adversely affected. 
Varied methods of data analysis in this study, from both network and 
enrichment analysis, provided biologically meaningful insight to malathion-
responsive genes.  Several gene annotations were found to have both high hub 
scores and over-representation amongst community ontologies supporting their 
likely involvement in malathion toxicity. Moreover, several unifying biological 
themes were represented in these analyses. Genes encoding for proteins 
involved in metabolism, metal ion homeostasis, oxidation reduction reactions, 
ATP binding, proteolysis, apoptosis, and neurodevelopment appear to correlate 
with a distinctive phenotype of subtle malathion toxicity. In combination, many of 
these processes have been linked to neuromuscular disorders as previously 
mentioned, due to a cellular disturbance in energetic processes or homeostasis 
(including metal ion homeostasis, mitochondrial respiration, or lipid metabolism).  
 This research shows a snapshot of the transcriptional response to 
malathion treatment and the impact of low, persistent environmental levels on 
early life stages of development in fish. It has been shown that malathion 
exposure results in dysregulation of transcripts involved mainly in metabolism, 
oxidoreductase activity, anatomical structure development, metal ion 
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homeostasis, apoptosis, signal transduction, cytoskeleton development and cell 
cycle events. Among dysregulated genes, HSP30 paralogs C and D showed 
strong malathion responsiveness and are put forth as candidate biomarkers of 
exposure to environmentally relevant high doses of malathion. Additionally, we 
found induction patterns to differ between CYP 1A1 and CYP 1A3, where CYP 
1A3 expression was found to be malathion inducible but CYP 1A1 was not.   
Interestingly, CYP 1A3 induction by malathion was found to be specific to a later 
developmental life stage (swim-up fry), which could explain differences in toxic 
susceptibility between life stages as observed through mortality and morbidity.   
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